Stock listing

Bioxyne Limited

Selected listing: PR8 · FWB · EUR · DE

Bioxyne Limited (Frankfurt:PR8), Commercial Services. Latest release May 21, 2026: Notice of General Meeting/Proxy Form.

PR8:FWBEURDEUpdated October 4, 2026

Ticker: Frankfurt:PR8
Asset type: Stock
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Exchange: Frankfurt
Currency: EUR

About Bioxyne Limited

The company focuses on developing and commercializing health and wellness products. Bioxyne is committed to innovation in the biotechnology sector, aiming to improve the quality of life through its offerings.

Latest news from Bioxyne Limited

Notice of General Meeting/Proxy Form

May 21, 2026

Secures $50m Exclusive German Supply Agreement with ADREX

May 11, 2026

Expands LATAM Footprint First Supply Agreement Costa Rica

May 10, 2026

Manufacturing Agreement Aurora Supplementary Information

March 31, 2026

Bioxyne Signs Manufacturing Agreement with Aurora Cannabis

March 31, 2026

All Bioxyne Limited news →

Research Bioxyne Limited

Bioxyne Limited company profile

View the public company page for Bioxyne Limited on 6ix.

Bioxyne Limited news

Read company news and market updates connected to Bioxyne Limited.

Bioxyne Limited investor events

Find investor webinars, events, and replay context for Bioxyne Limited.